A recently developed tobramycin preparation for inhalation (TOBIเฎพ, Pathogenesis Corp., Seattle, WA) is widely used in CF patients. It is often used in conjunction with intravenous tobramycin. Renal and ototoxicity associated with the use of tobramycin require that serum drug concentrations be monito
โฆ LIBER โฆ
Elevation of nitrotyrosine and nitrate concentrations in cystic fibrosis sputum
โ Scribed by Kimberly L. Jones; Alaa H. Hegab; Bettina C. Hillman; Keith L. Simpson; Patricia A. Jinkins; Matthew B. Grisham; Michael W. Owens; Etsuro Sato; Richard A. Robbins
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 134 KB
- Volume
- 30
- Category
- Article
- ISSN
- 8755-6863
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Falsely elevated serum tobramycin concen
โ
Okan Elidemir; Stephanie R. Maciejewski; Christopher M. Oermann
๐
Article
๐
2000
๐
John Wiley and Sons
๐
English
โ 24 KB
Effects of sputum oscillations and rhDNa
โ
Bonnie Dasgupta; Neil E. Brown; Malcolm King
๐
Article
๐
1998
๐
John Wiley and Sons
๐
English
โ 61 KB
๐ 2 views
Mucolytic treatment with rhDNase is part of the current therapy for cystic fibrosis (CF) lung disease. The Flutterเฎพ valve, a device for enhancing airway mucus clearance, has recently been approved for use in CF patients. Exhalation through the Flutterเฎพ valve leads to oscillations of expiratory airfl
A rapid HPLC method with fluorometric de
โ
Stefanie Redmann; Bruce G. Charles
๐
Article
๐
2006
๐
John Wiley and Sons
๐
English
โ 145 KB
๐ 1 views